Filter
472
Filtered Results: 472
Text search:
pyrazinamide
Featured
Recommendations
70
New Publications
131
Language
Document type
No document type
319
Guidelines
78
Manuals
26
Studies & Reports
21
Training Material
12
Strategic & Response Plan
7
Fact sheets
7
Situation Updates
2
Countries / Regions
Western and Central Europe
25
India
25
Nepal
14
Eastern Europe
12
Kenya
11
Argentina
11
Senegal
8
Peru
8
Tanzania
8
Bangladesh
8
Ethiopia
8
South Africa
7
Uganda
7
Malawi
6
Germany
6
Paraguay
6
Indonesia
6
Ukraine
5
Bolivia
5
Zambia
5
Colombia
4
Nigeria
4
Philippines
4
Mozambique
4
Cambodia
4
Brazil
4
Russia
4
Namibia
4
El Salvador
3
Lesotho
3
Ghana
3
Rwanda
3
Latin America and the Carribbean
3
Congo, Democratic Republic of
3
Botswana
3
Ecuador
3
Myanmar / Burma
3
Eswatini/ Swaziland
3
Benin
2
Cameroon
2
Burkina Faso
2
Zimbabwe
2
Haiti
2
Tajikistan
1
Switzerland
1
Gambia
1
Chile
1
Malaysia
1
Asia
1
Venezuela
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Uruguay
1
Romania
1
Central African Republic
1
Chad
1
Libya
1
Bhutan
1
Liberia
1
Solomon Islands
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
129
TB
60
Drugs & Medical Equipment
38
Guidelines
34
Studies & Reports
19
Pediatrics
15
Capacity Building
13
Women & Child Health
9
Paediatrics
8
Policies
7
Demograhic Health Surveys DHS
5
Community Health
5
Disease Prevention & Control
5
Bacteriology
4
COVID-19
3
Countries
3
Statistics
3
HIV & STI
3
Clinical Guidelines
2
Communicable Diseases
2
NTDs & Others
2
Communicable Diseases
1
Dental & Eye Care
1
Clinical Training
1
Public Health
1
Under-5 nutrition
1
Child Health
1
Buruli Ulcer
1
Diabetes
1
Dermatology
1
Maternal & Child Health
1
Public Health
1
Vaccine-preventable Diseases
1
Information, Education and Communication (IEC)
1
Quality Control & Assurance
1
Reproductive Health
1
Toolboxes
Drug resistant TB
43
Adults
30
Children
26
Detection & Diagnosis
24
Essential Medicines & Devices Lists
22
Training
18
Prevention & Control
12
Childhood TB
10
General
10
TB/HIV Coinfection
10
Argentina
9
TB & Prisoners
9
Peru
8
Other Countries
8
Research & Access
8
TB
8
Essential Medicines
6
Romania
6
Tuberculosis
6
Germany
6
Clinical Aspects
5
Children & Adolescents
5
IEC Materials
5
Brazil
5
HIV &TB
5
Disease Prevention & Control
5
Nutrition
5
TB & Drug Abuse
4
Moldova
4
Treatment & Prevention
4
Communication & Training
4
South-east Asia Region
4
Kenya
4
Policies & Strategies
3
Vaccines & Immunization
3
Ukraine
3
Laboratory
3
TB & Other Vulnerable Populations
3
Ethiopia
3
Essential List
3
Hospital Readiness/Essential Health Services
3
Colombia
3
El Salvador
3
Falsified & Substandard
3
Malawi
3
Clinical Guidelines
3
Eastern Europe & Central Asia
3
Country specific
2
South Africa
2
Eastern Mediterranean Region
2
Namibia
2
TB
2
Mozambique
2
Country Guidelines
2
Reports
2
Country Specific
2
TB/HIV
2
TB/COVID-19
2
Latin America
2
Ecuador
2
Prices and Patents
2
Model Formulary
2
Pharmacy Practice
2
Policies and guidelines
2
Uganda
2
HIV and coinfection
2
Kazakhstan
2
Western & Central Europe
2
AmR (Region of Americas)
2
Epidemiology
2
Biosafety
1
Azerbaijan
1
Clinical Aspects, Treatment & Prevention
1
Policies & Strategies
1
Clinical Guidelines
1
Pediatrics
1
Opportunistic Infections
1
Prevention Guidelines
1
National Policies
1
Social Worker
1
Eastern Europe
1
HIV
1
Global
1
People who injecting Drugs
1
Rwanda
1
Prophylaxis
1
Vaccination
1
Health & Refugee
1
Georgia
1
Drug resistance
1
Workplace
1
Belarus
1
HIV / AIDS
1
Medical professionals
1
Russia
1
DR Congo
1
Clinical Guidelines
1
Country specific documents
1
Essential Medicines & Medical Devices
1
Community Health Workers CHW
1
Advocacy & Communication
1
Chile
1
Rational use of Medicine
1
Health Worker
1
General
1
Botswana
1
Co-Morbidities (except TB)
1
Neurological Disorders
1
Ghana
1
Community Worker
1
TB/HIV Global
1
Lesotho
1
Latin America & the Carribean
1
Clinical Guidelines
1
Nigeria
1
Tajikistan
1
Antiretroviral Treatment ART
1
Preparedness & Prevention
1
Case Definitions
1
Prisoners
1
Meningitis & Encephalitis
1
Volunteers
1
SEAR (South-east Asia Region)
1
National Tuberculosis Control Program; Mycobacterial Disease Control National AIDS/STD Program
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of Drug Resistant TB" (PMD...
The term "Programmatic Management of Drug Resistant TB" (PMD...
This guide provides practical, step-by-step guidance on how to organize, implement, and monitor community-based care for DR TB. It is equally useful for program planning or supervision. The target audience for this guide is TB Program Managers, governments, policy makers, nongovernmental organizatio...
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
NEMLIST | Sixth Edition | February 2016
Third Edition: Revised October 2012
Journal of Tuberculosis Research, 2016, 4, 1-8
Published Online March 2016 in SciRes. http://www.scirp.org/journal/jtr
http://dx.doi.org/10.4236/jtr.2016.41001
WHO today published the new edition of its Model Lists of Essential Medicines and Essential Medicines for Children, which include new treatments for various cancers, insulin analogues and new oral medicines for diabetes, new medicines to assist people who want to stop smoking, and new antimicrobials...
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, ...
A survey of prevention, testing and treatment policies and practices
National Action Plan: Programmatic Management of Drug Resistance Tuberculosis, Tuberculosis Control Indonesia
2nd edition
Accessed at March 2014
guidance for health managers, health workers, and activists
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be increased by improving access to the highest-ranked med...
